Healthcare - Biotechnology - NASDAQ - US
$ 0.186
0 %
$ 332 M
Market Cap
-0.05
P/E
BALANCE SHEET
94.9 M
ASSETS
16.5 M
LIABILITIES
78.4 M
EQUITY
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition
Jasper Therapeutics, Inc.
| Current Assets | 88.9 M |
| Cash & Short-Term Investments | 86.9 M |
| Receivables | 250 K |
| Other Current Assets | 1.8 M |
| Non-Current Assets | 5.95 M |
| Long-Term Investments | 0 |
| PP&E | 4.19 M |
| Other Non-Current Assets | 1.76 M |
| Current Liabilities | 12.4 M |
| Accounts Payable | 4.15 M |
| Short-Term Debt | 1.94 M |
| Other Current Liabilities | 6.28 M |
| Non-Current Liabilities | 4.08 M |
| Long-Term Debt | 1.81 M |
| Other Non-Current Liabilities | 2.26 M |
Balance Sheet
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | |
|---|---|---|---|---|---|
| ASSETS | |||||
| Cash & Cash Equivalents | 86.9 | 38.2 | 84.7 | 19.8 | 27.2 |
| Short Term Investments | 0 | 0 | 0 | 0 | 100.2 |
| Receivables | 0.2 | 0 | 0 | 0.6 | 0 |
| Inventory | 0 | 0 | (0.5) | 95.5 K | 0 |
| Other Current Assets | 1.8 | 3.5 | 3.1 | 43 K | 0 |
| Total Current Assets | 88.9 | 41.7 | 87.8 | 20.7 | 27.2 |
| PP&E | 4.2 | 5.5 | 4.8 | 2.0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 |
| Goodwill | 0 | 0 | 0 | 0 | 0 |
| Long Term Investments | 0 | 0.4 | 0.3 | 0.3 | 0 |
| Other Long Term Assets | 1.8 | 1.2 | 1.0 | 0.6 | 48 K |
| Other Assets | 0 | 0 | 0 | 0 | 0 |
| Total Assets | 94.9 | 48.4 | 93.7 | 23.4 | 27.2 |
| LIABILITIES | |||||
| Accounts Payable | 4.1 | 1.8 | 3.9 | 1.4 | 0.6 |
| Short Term Debt | 1.9 | 1.7 | 1.0 | 0 | 0 |
| Other Current Liabilities | 6.3 | 3.6 | 3.1 | 2.6 | 1.4 |
| Total Current Liabilities | 12.4 | 7.1 | 8.0 | 4.0 | 2.0 |
| Long Term Debt | 1.8 | 2.8 | 2.4 | 1.6 | 0 |
| Deferred Tax Income | 0 | 0.6 | 0.3 | 0.4 | 0 |
| Other Liabilities | 2.3 | 2.5 | 13.7 | 52.9 | 0 |
| Total Liabilities | 16.5 | 12.4 | 24.1 | 58.5 | 2.0 |
| EQUITY | |||||
| Common Stock | 1 K | 4 K | 4 K | 1 K | 10 K |
| Retained Earnings | (169.6) | (105.1) | (67.5) | (36.8) | (5.1) |
| Other Accumulative Comprehensive Income/Loss | 0 | 0 | (93.7) | (43.8) | 0 |
| Total Equity | 78.4 | 36.0 | 69.5 | (35.1) | 21.1 |
| Total Liabilities and Equity | 94.9 | 48.4 | 93.7 | 23.4 | 23.1 |
| SHARES OUTSTANDING | |||||
| Common Shares Outstanding | 10.4 | 3.6 | 1.1 | 0.3 | 0 |